Annexon Ownership
| ANNX Stock | USD 2.60 0.07 2.77% |
Annexon |
Annexon Stock Ownership Analysis
About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Annexon recorded a loss per share of 1.01. The entity had not issued any dividends in recent years. Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company was incorporated in 2011 and is headquartered in Brisbane, California. Annexon operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people. For more info on Annexon please contact JD Esq at 650 822 5500 or go to https://www.annexonbio.com.Besides selling stocks to institutional investors, Annexon also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Annexon's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Annexon's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Annexon Quarterly Liabilities And Stockholders Equity |
|
Annexon Insider Trades History
Less than 1% of Annexon are currently held by insiders. Unlike Annexon's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Annexon's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Annexon's insider trades
Annexon Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Annexon is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Annexon backward and forwards among themselves. Annexon's institutional investor refers to the entity that pools money to purchase Annexon's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Woodline Partners Lp | 2024-12-31 | 2.7 M | Logos Global Management Lp | 2024-12-31 | 2.5 M | Candriam Luxembourg S.c.a. | 2024-12-31 | 2.5 M | Sio Capital Management, Llc | 2024-12-31 | 2.4 M | Geode Capital Management, Llc | 2024-12-31 | 2.2 M | Jpmorgan Chase & Co | 2024-12-31 | 1.5 M | Polygon Management Ltd | 2024-12-31 | 1.4 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.4 M | Goldman Sachs Group Inc | 2024-12-31 | 1.3 M | Fmr Inc | 2024-12-31 | 14.2 M | Blackrock Inc | 2024-12-31 | 8.5 M |
Annexon Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Annexon insiders, such as employees or executives, is commonly permitted as long as it does not rely on Annexon's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Annexon insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Annexon Outstanding Bonds
Annexon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Annexon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Annexon bonds can be classified according to their maturity, which is the date when Annexon has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Annexon Corporate Filings
8K | 3rd of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
| 31st of January 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Annexon Stock Analysis
When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.